Goodbody Health Limited
GDBYF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $505 | $71 | $204 | $235 |
| - Cash | $3,050 | $3,737 | $5,938 | $6,068 |
| + Debt | $139 | $250 | $292 | $337 |
| Enterprise Value | -$2,406 | -$3,416 | -$5,442 | -$5,496 |
| Revenue | $1,886 | $2,235 | $5,169 | $7,183 |
| % Growth | -15.6% | -56.8% | -28% | – |
| Gross Profit | $847 | $1,015 | $2,604 | $3,628 |
| % Margin | 44.9% | 45.4% | 50.4% | 50.5% |
| EBITDA | -$842 | -$881 | $218 | $282 |
| % Margin | -44.6% | -39.4% | 4.2% | 3.9% |
| Net Income | -$1,266 | -$1,146 | -$266 | -$1,046 |
| % Margin | -67.1% | -51.3% | -5.1% | -14.6% |
| EPS Diluted | -0.035 | -0.031 | -0.007 | 0 |
| % Growth | -10.5% | -330.1% | – | – |
| Operating Cash Flow | -$752 | -$1,994 | -$11 | $2,083 |
| Capital Expenditures | -$41 | -$189 | -$80 | -$95 |
| Free Cash Flow | -$793 | -$2,183 | -$91 | $1,987 |